People Background Check
Find People:

Edward W Pham, Age 512444 Fairglen Dr, San Jose, CA 95125

Get Report
Known as:
Ed W Pham Heather Pham
Related to:
Trang D Nguyen 59

Edward Pham Phones & Addresses

2444 Fairglen Dr, San Jose, CA 95125

1914 Garden Bing Cir, San Jose, CA 95131

1109 King Rd, San Jose, CA 95122

Indianapolis, IN

510 Mansion Ct, Santa Clara, CA 95054

Social networks

Edward W Pham

Linkedin

Work

Company: Cisco Nov 1997 to Apr 2017 Position: Consulting systems engineer

Education

Degree: Master of Science, Masters School / High School: Stanford University Aug 1997 to 1999 Specialities: Computer Science

Skills

Tcp/Ip • Snmp • Cisco Ios • Cisco Technologies • Perl • Routing • Network Security • Data Center • Qos • Integration • Linux • C • Python • Virtualization • C++ • Java • Git • Vmware Vsphere • Xml • Nx Os • Xmpp • Netconf • Debugging • Rest • Ldap • Lan Switching • Catalyst Switches • Cisco Nexus • Vmware Vcenter • Design Patterns • Puppet • Chef • Container • Software Development • Networking • Network Management Applications • Yang • Restconf • Pre Sales • Enterprise Software • Unified Communications • Ccie • Cisco Certified • Cisco Certified Internetwork Expert • Cisco Systems Products • Network Architecture • Voip • Cloud Collaboration • Hybrid Cloud

Ranks

Certificate: License 6275

Interests

Children

Industries

Computer Networking

Mentions for Edward W Pham

Edward Pham resumes & CV records

Resumes

Edward Pham Photo 31

Product Sales Specialist

Location:
316 Bricknell Dr, Coppell, TX 75019
Industry:
Computer Networking
Work:
Cisco Nov 1997 - Apr 2017
Consulting Systems Engineer Cisco Nov 1997 - Apr 2017
Product Sales Specialist Cisco Apr 2012 - Apr 2012
Technical Leader Cisco Jul 1999 - Jul 2010
Senior Software Engineer Cisco 2006 - 2007
Software Qa Cisco 1997 - 2006
Customer Support Engineer Amd Jan 1995 - Jul 1999
Cad Design Engineer Cisco Jan 1995 - Jul 1999
Solutions Test Engineer
Education:
Stanford University Aug 1997 - 1999
Master of Science, Masters, Computer Science Rose - Hulman Institute of Technology 1992 - 1996
Bachelors, Bachelor of Science, Chemical Engineering University of California, Berkeley 1993 - 1995
Bachelors, Bachelor of Science
Skills:
Tcp/Ip, Snmp, Cisco Ios, Cisco Technologies, Perl, Routing, Network Security, Data Center, Qos, Integration, Linux, C, Python, Virtualization, C++, Java, Git, Vmware Vsphere, Xml, Nx Os, Xmpp, Netconf, Debugging, Rest, Ldap, Lan Switching, Catalyst Switches, Cisco Nexus, Vmware Vcenter, Design Patterns, Puppet, Chef, Container, Software Development, Networking, Network Management Applications, Yang, Restconf, Pre Sales, Enterprise Software, Unified Communications, Ccie, Cisco Certified, Cisco Certified Internetwork Expert, Cisco Systems Products, Network Architecture, Voip, Cloud Collaboration, Hybrid Cloud
Interests:
Children
Certifications:
License 6275
Ccie Voice/Collaboration
Ccie Routing and Switching

Publications & IP owners

Us Patents

Methods To Treat Viral Infections

US Patent:
2022034, Nov 3, 2022
Filed:
Jun 9, 2020
Appl. No.:
17/617267
Inventors:
- Stanford CA, US
Edward A. Pham - Palo Alto CA, US
Anming Xiong - Redwood City CA, US
International Classification:
A61K 38/17
A61K 38/21
A61P 31/20
Abstract:
Methods and compositions are provided for reducing virus titer and eliminating virus-infected cells from an individual.

Pan-Genotypic Agents Against Influenza Virus And Methods Of Using The Same

US Patent:
2022024, Aug 4, 2022
Filed:
Apr 8, 2022
Appl. No.:
17/716497
Inventors:
- Stanford CA, US
Rachel Hagey Saluti - Stanford CA, US
Edward A. Pham - Palo Alto CA, US
International Classification:
C12N 15/11
A61P 31/16
Abstract:
Methods of inhibiting influenza A virus in a sample are provided. Aspects of the methods include contacting a sample comprising viral RNA (vRNA) having a PSL2 motif with an effective amount of an agent that specifically binds the PSL2 motif to inhibit the influenza A virus. Also provided are methods of treating or preventing influenza A virus infection in a subject. Also provided are methods for screening a candidate agent for the ability to inhibit influenza A virus in a cell, the method comprising: contacting a sample with a candidate agent; and determining whether the candidate agent specifically binds to the PSL2 motif of vRNA. Also provided are compounds and pharmaceutical compositions comprising an oligonucleotide sequence complementary to a PB2 vRNA region that find use in the subject methods.

Pan-Genotypic Agents Against Influenza Virus And Methods Of Using The Same

US Patent:
2023007, Mar 9, 2023
Filed:
Aug 1, 2022
Appl. No.:
17/878433
Inventors:
- Stanford CA, US
Rachel Hagey Saluti - Stanford CA, US
Edward A. Pham - Palo Alto CA, US
International Classification:
C12N 15/113
A61P 31/16
A61K 45/06
Abstract:
Methods of inhibiting a respiratory virus, (i.e., a virus associated with a respiratory condition, e.g., influenza A, influenza B, RSV, etc.) in a sample are provided. Aspects of the methods include contacting a sample comprising viral RNA (vRNA) having a target motif with an effective amount of an agent that specifically binds the target motif to inhibit the respiratory virus. Also provided are methods of treating or preventing respiratory virus infection in a subject. Also provided are compounds and pharmaceutical compositions comprising an oligonucleotide sequence complementary to a target vRNA region that find use in the subject methods.

Pan-Genotypic Agents Against Influenza Virus And Methods Of Using The Same

US Patent:
2020023, Jul 30, 2020
Filed:
Feb 14, 2020
Appl. No.:
16/792103
Inventors:
- Stanford CA, US
Rachel Hagey Saluti - Stanford CA, US
Edward A. Pham - Palo Alto CA, US
International Classification:
C12N 15/11
A61P 31/16
Abstract:
Methods of inhibiting influenza A virus in a sample are provided. Aspects of the methods include contacting a sample comprising viral RNA (vRNA) having a PSL2 motif with an effective amount of an agent that specifically binds the PSL2 motif to inhibit the influenza A virus. Also provided are methods of treating or preventing influenza A virus infection in a subject. Also provided are methods for screening a candidate agent for the ability to inhibit influenza A virus in a cell, the method comprising: contacting a sample with a candidate agent; and determining whether the candidate agent specifically binds to the PSL2 motif of vRNA. Also provided are compounds and pharmaceutical compositions comprising an oligonucleotide sequence complementary to a PB2 vRNA region that find use in the subject methods.

Chloroquine Stereoisomer For Treating Tuberculosis Related Diseases

US Patent:
2016011, Apr 28, 2016
Filed:
Oct 20, 2015
Appl. No.:
14/918404
Inventors:
- Stanford CA, US
Jeffrey S. Glenn - Palo Alto CA, US
Rajiv Lochan Gaur - Palo Alto CA, US
Tran Van - Stanford CA, US
Gary K. Schoolnik - Stanford CA, US
Edward Pham - Stanford CA, US
International Classification:
A61K 31/4706
A61K 45/06
Abstract:
This disclosure provides a method of treating a subject infected with a mycobacteria of the complex or infected with an atypical . Aspects of the method include administering to a subject in need thereof a therapeutically effective amount of an enantiomerically pure (R)-chloroquine agent. The (R)-chloroquine agent may be an analog or derivate of chloroquine having a particular stereochemistry at the position located alpha to the amino-quinoline core of the chloroquine agent. Also provided are methods of inhibiting mycobacteria of the complex or other atypical mycobacteria in a cell. Kits and pharmaceutical compositions for practicing the subject methods are also provided.

Possible Relatives

Cynthia Pham  David H Pham  Davis T Pham  Dean D Pham  Dac T Pham  Dai V Pham  Daisy D Pham  Edward M Johnson  Edward M Stan  Edward W Stanchak 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.